Two Immune Cell Armies in One Infusion: Combination NK and T Cell Therapy Shows Promise in Hard-to-Treat Tumors
A phase 1 trial found that an autologous combination of natural killer cells and tumor-primed T lymphocytes was safe and ...
A phase 1 trial found that an autologous combination of natural killer cells and tumor-primed T lymphocytes was safe and ...
Researchers at Bar-Ilan University and the Weizmann Institute used computational protein design to create an enhanced T-cell receptor, called SET, ...
Researchers at Trinity College Dublin report that KHYG-1 natural killer cells retain their cancer-killing function after exposure to the tumour ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine